Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:selinexor
go back to main search page
Accession:CHEBI:229764 term browser browse the term
Definition:A member of the class of triazoles that is 1H-1,2,4-triazole substituted by (1Z)-3-oxo-3-[2-(pyrazin-2-yl)hydrazinyl]prop-1-en-1-yl and 3,5-bis(trifluoromethyl)phenyl groups at positions 1 and 3, respectively. It is a prescription medicine approved for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma.
Synonyms:related_synonym: (2Z)-3-{3-[3,5-bis(trifluoromethyl)phenyl]-1H-1,2,4-triazol-1- yl}-N'-(pyrazin-2-yl)prop-2-enehydrazide;   Formula=C17H11F6N7O;   InChI=1S/C17H11F6N7O/c18-16(19,20)11-5-10(6-12(7-11)17(21,22)23)15-26-9-30(29-15)4-1-14(31)28-27-13-8-24-2-3-25-13/h1-9H,(H,25,27)(H,28,31)/b4-1-;   InChIKey=DEVSOMFAQLZNKR-RJRFIUFISA-N;   KPT 330;   SMILES=FC(F)(F)C1=CC(=CC(=C1)C1=NN(\\C=C/C(=O)NNC2=NC=CN=C2)C=N1)C(F)(F)F;   Xpovio;   selinexorum
 xref: DrugBank:DB11942;   HMDB:HMDB0258217;   KEGG:D11222
 xref_mesh: MESH:C585161
 xref: PMID:23373539;   PMID:27893412;   PMID:28314790;   PMID:28810913;   PMID:28852098;   PMID:29707241;   PMID:30064906;   PMID:30115935;   PMID:30996012;   PMID:32598257;   PMID:33403670;   PMID:33507295;   PMID:33601919;   PMID:34488662;   PMID:34669417;   PMID:34741230;   PMID:35355406;   PMID:35477814;   PMID:35667526;   PMID:35941226;   PMID:36180918;   PMID:36200270;   PMID:36622814;   PMID:36731340;   PMID:36827679;   PMID:36847599;   PMID:37016732;   PMID:37046649;   PMID:37047788;   PMID:37079389;   PMID:37094850;   PMID:37126200;   PMID:37175668;   PMID:37184196;   PMID:37191210;   PMID:37346402;   PMID:37595020;   PMID:37715291;   PMID:37760508;   PMID:37945593;   PMID:38105606;   PMID:38186637;   PMID:38454813;   Wikipedia:Selinexor



show annotations for term's descendants           Sort by:
selinexor term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Atm ATM serine/threonine kinase multiple interactions ISO [selinexor co-treated with INCB057643] results in decreased phosphorylation of ATM protein CTD PMID:37899423 NCBI chr 8:53,828,741...53,932,773
Ensembl chr 8:53,831,093...53,932,437
JBrowse link
G Atr ATR serine/threonine kinase multiple interactions ISO [selinexor co-treated with INCB057643] results in decreased phosphorylation of ATR protein CTD PMID:37899423 NCBI chr 8:96,426,704...96,524,152
Ensembl chr 8:96,426,724...96,524,136
JBrowse link
G Bbc3 Bcl-2 binding component 3 multiple interactions
increases expression
ISO [INCB057643 co-treated with selinexor] results in increased expression of BBC3 protein
selinexor results in increased expression of BBC3 protein
CTD PMID:37899423 NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions ISO [selinexor co-treated with INCB057643] results in decreased phosphorylation of CHEK1 protein CTD PMID:37899423 NCBI chr 8:36,420,565...36,443,477
Ensembl chr 8:36,420,569...36,441,009
JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions ISO [selinexor co-treated with INCB057643] results in decreased phosphorylation of CHEK2 protein CTD PMID:37899423 NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
JBrowse link
G H2ax H2A.X variant histone increases expression
multiple interactions
ISO selinexor results in increased expression of H2AX protein
[selinexor co-treated with INCB057643] results in increased expression of H2AX protein
CTD PMID:37899423 NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
JBrowse link
G Mdm2 MDM2 proto-oncogene increases expression
multiple interactions
ISO selinexor results in increased expression of MDM2 protein
[INCB057643 co-treated with selinexor] results in increased expression of MDM2 protein
CTD PMID:37899423 NCBI chr 7:53,290,660...53,315,205
Ensembl chr 7:53,290,664...53,314,915
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions
decreases expression
ISO INCB057643 promotes the reaction [selinexor results in decreased expression of MYC mRNA]; INCB057643 promotes the reaction [selinexor results in decreased expression of MYC protein]; selinexor promotes the reaction [INCB057643 results in decreased expression of MYC mRNA]; selinexor promotes the reaction [INCB057643 results in decreased expression of MYC protein]
selinexor results in decreased expression of MYC mRNA; selinexor results in decreased expression of MYC protein
CTD PMID:37899423 NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
JBrowse link
G Pmaip1 phorbol-12-myristate-13-acetate-induced protein 1 multiple interactions ISO [INCB057643 co-treated with selinexor] results in increased expression of PMAIP1 protein CTD PMID:37899423 NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
JBrowse link
G Tp53 tumor protein p53 increases expression
multiple interactions
ISO selinexor results in increased expression of TP53 protein
[INCB057643 co-treated with selinexor] results in increased expression of TP53 protein
CTD PMID:37899423 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
JBrowse link
G Tp73 tumor protein p73 increases expression ISO selinexor results in increased expression of TP73 protein CTD PMID:37899423 NCBI chr 5:164,621,377...164,703,958
Ensembl chr 5:164,621,377...164,681,128
JBrowse link
G Wee1 WEE1 G2 checkpoint kinase multiple interactions ISO [selinexor co-treated with INCB057643] results in decreased phosphorylation of WEE1 protein CTD PMID:37899423 NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19808
    role 19784
      application 19627
        anti-inflammatory agent 16580
          selinexor 12
Path 2
Term Annotations click to browse term
  CHEBI ontology 19808
    subatomic particle 19806
      composite particle 19806
        hadron 19806
          baryon 19806
            nucleon 19806
              atomic nucleus 19806
                atom 19806
                  main group element atom 19756
                    p-block element atom 19756
                      carbon group element atom 19705
                        carbon atom 19702
                          organic molecular entity 19702
                            heteroorganic entity 19460
                              organochalcogen compound 19224
                                organooxygen compound 19141
                                  carbon oxoacid 18612
                                    carboxylic acid 18609
                                      carboacyl group 17677
                                        univalent carboacyl group 17677
                                          carbamoyl group 17526
                                            carboxamide 17526
                                              alpha,beta-unsaturated carboxylic acid amide 7089
                                                enamide 7089
                                                  selinexor 12
paths to the root